PEMF for
Golfer's Elbow.

June 2026 · 9 min read · Sports Medicine Protocol

What Is Golfer's Elbow?

Medial epicondylitis — commonly called golfer's elbow — is a degenerative tendinopathy of the common flexor-pronator tendon origin at the medial epicondyle of the humerus. The involved tendons are the pronator teres, flexor carpi radialis, flexor carpi ulnaris, and palmaris longus. Repetitive forearm flexion-pronation loads produce microtrauma and angiofibroblastic degeneration: disorganized collagen, neovascularization, and a failed healing response that maintains the condition as chronic.

Prevalence is 1–3% of adults, rising to 4–9% in manual laborers, golfers, baseball pitchers, climbers, and racquet sport athletes. In the Philippines, the condition is under-recognized in the manual labor population — construction workers, mechanics, and assembly-line workers — where repetitive forearm loading is occupational, not recreational. This represents a significant, accessible treatment market for Philippine PEMF clinics.

Why Golfer's Elbow Is Difficult to Treat Conventionally

The core pathology is tendinosis — not tendinitis. The tendon is not acutely inflamed; it is chronically degenerated. This explains why NSAIDs and corticosteroid injections provide only temporary relief: they suppress pain signaling without addressing the structural disruption of collagen architecture. In the medium term, repeated corticosteroid injections are associated with further collagen disruption and reduced tendon tensile strength.

Rest and activity modification allow pain to settle but do not restore collagen organization. Physiotherapy with eccentric loading is effective over 12–24 weeks but slow. Platelet-rich plasma (PRP) injection shows promise but is expensive (₱15,000–₱40,000 per injection in the Philippines) and lacks consistent RCT evidence. This treatment gap positions PEMF as the most cost-effective, evidence-informed option for accelerating tendon healing at the cellular level.

How PEMF Repairs Tendinopathic Tissue

PEMF acts on medial epicondylitis through four well-characterized mechanisms:

1. Collagen fiber realignment: PEMF promotes fibroblast proliferation and type I collagen synthesis, with demonstrable realignment of disorganized collagen fibers toward a longitudinally ordered architecture — the critical structural repair that NSAIDs and injections cannot achieve. This was confirmed in Achilles tendinopathy tissue models (PMC7093940), with direct applicability to elbow tendon pathology.
2. Anti-inflammatory cytokine suppression: While true tendinosis lacks acute inflammation, the local microenvironment contains elevated prostaglandins, substance P, and neuropeptides that maintain pain sensitization. PEMF suppresses these mediators through NF-κB inhibition and adenosine-A2A receptor activation — reducing the chemical pain signal without systemic drug exposure.
3. Microcirculation enhancement: Tendinopathic tissue is metabolically compromised due to reduced vascularity. PEMF promotes nitric oxide (NO)-mediated arteriolar dilation, improving local oxygen delivery and metabolic waste clearance — creating a favorable healing environment.
4. Pain gate modulation: PEMF raises the firing threshold of A-δ and C fibers, providing direct analgesic effect from the first sessions. This allows patients to begin functional loading exercises earlier — a prerequisite for complete tendon remodeling.

The Clinical Evidence Base

Golfer's elbow and tennis elbow (lateral epicondylitis) share identical histopathology — angiofibroblastic tendon degeneration — making the lateral epicondylitis RCT evidence directly applicable to medial presentations. The evidence base is substantial:

PEMF vs. Corticosteroid vs. Sham (RCT, n=60)

Uzunca et al. (Clinical Rheumatology, 2004, PMID 16633709) conducted a three-arm RCT (n=60) comparing PEMF, corticosteroid injection, and sham PEMF over 3 months for lateral epicondylitis. At 3 months, PEMF produced outcomes equivalent to corticosteroid injection for pain reduction, grip strength, and function — without any injection-related adverse events. At 6 months, the PEMF group maintained gains; the corticosteroid group showed partial recurrence.

VAS 7.82→3.11 in 3 Weeks (Saudi Journal of Sports Medicine)

A prospective study using PEMF for epicondylitis (Saudi Journal of Sports Medicine, 2017) documented remarkable short-term outcomes:

• Visual Analogue Scale (VAS): 7.82 → 3.11 (p<0.001) within 3 weeks
• Pressure Pain Threshold (PPT): 2.95 → 4.84 kg/cm² (p<0.001) — reflecting reduced mechanical sensitization
• Pain-Free Grip Strength (PFGS): 18.6 → 22.1 kg (p<0.001) — the primary functional outcome measure

These changes represent clinically meaningful recovery in pain, tenderness, and function within a 3-week treatment window.

2026 Systematic Review: PEMF for Soft Tissue Injuries

A 2026 systematic review published in Frontiers in Sports and Active Living (doi:10.3389/fspor.2026.1694944) confirmed PEMF's efficacy across randomized controlled trials in soft tissue injuries, including tendinopathy. Key finding: PEMF consistently produced greater pain reduction and functional improvement than sham across RCTs of varying durations, with no serious adverse events reported across included trials.

Clinical Protocol: PEMF for Medial Epicondylitis

• Patient positioning: Seated with elbow resting on treatment table, forearm supinated (palm up) to expose medial epicondyle
• Coil placement: Focused coil centered directly over the medial epicondyle, encompassing the proximal flexor-pronator tendon insertion
• Frequency: 10–20 Hz (low frequency for anti-inflammatory and collagen-remodeling effects; can titrate to 25–50 Hz in later sessions to stimulate fibroblast proliferation)
• Intensity: 1–3 mT
• Session duration: 20–30 minutes
• Treatment course: 6–10 sessions, 2–3 times per week
• Adjunct: Eccentric wrist flexion exercises recommended starting at session 3–4, once pain threshold allows functional loading
• Expected response: VAS improvement typically begins by session 2–3; grip strength improvement by session 4–6; full tendon remodeling requires the complete course
• Philippine pricing: ₱1,500–₱2,500 per session; full course ₱9,000–₱25,000

Staging Protocol by Severity

PEMF vs. Standard Treatments

Philippine Market Opportunity

Elbow tendinopathy affects an estimated 2–4 million Filipinos at any given time. The market segments with highest clinical volume are: manual laborers in construction, manufacturing, and domestic work (forearm flexion overuse); BPO keyboard workers with sustained forearm pronation; and the rapidly growing recreational sports population in badminton, tennis, and golf. Clinics positioned in business districts and sports complexes will see the highest volume of epicondylitis presentations.

The PEMF advantage over competitor modalities (ultrasound, TENS, laser) is the combination of collagen remodeling and analgesic effect in a single treatment — a clinical proposition that justifies premium pricing and generates high treatment completion rates.

Contraindications

Standard PEMF contraindications apply: active pacemaker, pregnancy (near the treatment area), active epilepsy, active malignancy in the field. Elbow-area metal implants (e.g., previous elbow fracture ORIF hardware) require clinical judgment; non-ferromagnetic implants are generally not a contraindication. Patients with coagulation disorders should be assessed before treatment. Contraindications do not differ from standard PEMF application.

Frequently Asked Questions

How is golfer's elbow different from tennis elbow?

Both are epicondylitis — tendinosis at the elbow. Tennis elbow (lateral epicondylitis) affects the common extensor tendon at the lateral epicondyle; golfer's elbow affects the common flexor-pronator tendon at the medial epicondyle. The pathophysiology is identical (angiofibroblastic degeneration), and PEMF treats both through the same mechanism. Medial epicondylitis is typically more painful due to proximity of the ulnar nerve, which can be co-affected.

How many PEMF sessions are needed before returning to sport?

Most athletes can begin graduated sport-specific loading by sessions 4–6. Full return to unrestricted sport (e.g., golf swing, throwing) typically occurs after 8–10 sessions, when grip strength is within 90% of the unaffected side and VAS has dropped below 2/10 during sport-specific movement.

Can PEMF treat both medial and lateral epicondylitis in the same session?

Yes. If a patient has bilateral epicondylitis or both medial and lateral involvement in the same elbow (uncommon but seen in overhead athletes), both areas can be treated sequentially in the same session by repositioning the coil. Total session time extends to 40–50 minutes.

What happens if PEMF is combined with eccentric loading?

The combination is the current best-practice protocol. PEMF reduces the chemical pain sensitization that makes eccentric loading intolerable in the acute phase, enabling earlier rehabilitation. Early eccentric loading in turn provides the mechanical stimulus that guides PEMF-stimulated collagen synthesis into the correct fiber orientation. The two interventions are synergistic, not alternative.